A study in mice and human tissue suggests psilocybin protects against peripheral neuropathy, a common side effect of chemotherapy. The findings are so promising that researchers are starting a mid-stage clinical trial this year
Experts say the peptide craze is part of a broader phenomenon, as patients look beyond the regulated health system to address problems that doctors have struggled to treat
A study in mice found that a protein called saxiphilin acts like a sponge against a deadly toxin produced by algal blooms. The harmful agent, which accumulates in certain seafood, can cause a life-threatening illness called paralytic shellfish poisoning
The Food and Drug Administration just greenlit a medication called Orzeyful for the treatment of narcolepsy type 1 in adults. The condition is caused by the loss of brain cells that produce orexin, a chemical important for regulating the sleep-wake cycle
Recently FDA-approved treatments work to clear clumps of the protein amyloid beta in the brain. A drug that instead goes after tangles of the protein tau can yield similar cognitive outcomes, a new study suggests
The treatment consists of a Bluetooth headset that patients can connect to an app on their smartphones. It could mark a revolution in mental health medicine
T cells, which target infection and disease, can become more effective after a meal. The finding might help improve cancer-fighting therapies and optimize our response to vaccines
The agency’s decision is based on results from a clinical trial in which the treatment improved hearing in 80 percent of the pediatric participants. However, Deaf community advocates worry about the push to cure hearing loss
The patient was bedridden and needed daily blood transfusions, and she had tried nine different therapies that didn’t bring lasting effects. So, researchers modified some of her immune cells so they would attack her faulty cells
As ADHD Coaching Gains Popularity, Researchers Stress the Importance of Careful Vetting
A recent survey highlights variation in the training credentials and experience across the burgeoning industry, which is mostly unregulated and unlicensed
A recent study suggests that the large mammals may seek out parts of bananas and papayas when they’re suffering from gut parasites, sparking a cross-species exchange of pharmaceutical knowledge
The hormone estrogen—which female animals typically have more of than males—triggers a molecular cascade in the gut that leads to pain signals, a study in mice suggests
A wave of fresh science is challenging a century-old treatment and offering hope to the people snakebites harm most—often far from hospitals and help
Oliver Chu is one of five kids participating in a clinical trial investigating a gene therapy for Hunter syndrome, a disorder with symptoms akin to childhood dementia that limits life expectancy
Suffering From Sleep Apnea? Try Blowing Into a Conch Shell Almost Daily, New Study Suggests
Researchers say the practice might provide a simpler and low-cost alternative to the standard treatment for obstructive sleep apnea, though trials with more participants are needed
Cancer DNA Can Be Detected in the Bloodstream Up to Three Years Before Diagnosis, Study Suggests
For a few individuals, scientists found genetic material from cancerous tumors in blood samples taken years before they were diagnosed through traditional methods
In a Remarkable First, a Baby With a Rare Disease Receives Personalized Gene Therapy
Researchers say the CRISPR-based technique used could eventually be employed to treat more people with rare genetic diseases
Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson’s patients and found no adverse effects
New 3D Bioprinter Could Build Replicas of Human Organs, Offering a Boost for Drug Discovery
The invention uses light, sound and bubbles to quickly create copies of soft tissue that might one day support testing individualized therapies for cancer and other diseases
Weight Loss and Diabetes Drug Could Slow Alzheimer’s Progression, Preliminary Study Suggests
In a year-long trial, people who received a daily injection of liraglutide showed an 18 percent lower cognitive decline than people who received a placebo
Page 1 of 4